Skip to main content

Mucopolysaccharidosis Type VII News

Related terms: Sly Syndrome, MPS VII, GUSB Deficiency

FDA Approves Mepsevii (vestronidase alfa) for Mucopolysaccharidosis Type VII

November 15, 2017 – The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called...

Ask a question

To post your own question to this support group, sign in or create an account.